1.
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies. Swiss Med Wkly [Internet]. 2009 Jan. 24 [cited 2026 Jan. 13];139(0304):41-6. Available from:
https://smw.ch/index.php/smw/article/view/934